ShockWave Medical Inc (SWAV) gains 3.40% for July 21

Equities Staff  |

ShockWave Medical Inc (NASDAQ: SWAV) shares gained 3.40%, or $5.79 per share, to close Wednesday at $175.96. After opening the day at $171.53, shares of ShockWave Medical fluctuated between $176.97 and $169.44. 222,992 shares traded hands a decrease from their 30 day average of 352,761. Wednesday's activity brought ShockWave Medical’s market cap to $6,155,619,590.

ShockWave Medical is headquartered in Santa Clara, California..

About ShockWave Medical Inc

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave Medical aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which Shockwave Medical refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes.

Visit ShockWave Medical Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on ShockWave Medical Inc and to follow the company’s latest updates, you can visit the company’s profile page here: ShockWave Medical Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content